# FDA Inspection 1084234 - South Texas Blood and Tissue Center - March 04, 2019

Source: https://www.keypedia.com/records/fda_inspections/south-texas-blood-and-tissue-center/b899b3db-ff1f-462f-a8fa-849c5317cea0
Source feed: FDA_Inspections

> FDA Inspection 1084234 for South Texas Blood and Tissue Center on March 04, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1084234
- Company Name: South Texas Blood and Tissue Center
- Inspection Date: 2019-03-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1242024 - 2024-05-20](https://www.keypedia.com/records/fda_inspections/south-texas-blood-and-tissue-center/713af8ee-1270-483c-99a1-25572f5c65d7)
- [FDA Inspection 994663 - 2016-11-30](https://www.keypedia.com/records/fda_inspections/south-texas-blood-and-tissue-center/b5d51f27-33c6-48e9-9da6-0793a041ebd7)

Company: https://www.keypedia.com/companies/south-texas-blood-and-tissue-center/e5f1356b-a3bd-4d56-8395-6567e37b67f2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d